New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
10:21 EDTAPOL, SBGI, OHRP, IRM, UNXL, ACHN, FIO, MTOR, VRTXOptions with decreasing implied volatility
Options with decreasing implied volatility: OHRP VRTX ACHN SBGI MTOR UNXL APOL FIO IRM CBS
News For OHRP;VRTX;ACHN;SBGI;MTOR;UNXL;APOL;FIO;IRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 12, 2015
16:49 EDTVRTXVertex resumes after-hours trading, shares up 5.6% to $131.00
Subscribe for More Information
16:20 EDTVRTXVertex to resume trading at 14:45
16:19 EDTVRTXVertex confirms FDA panel voted 12-to-1 to recommend approval of Orkambi
Subscribe for More Information
16:16 EDTVRTXVertex confirms FDA panel voted 12-to-1 to recommend approval of Orkambi
16:16 EDTVRTXPiper Jaffray remains confident in approval for Vertex
Subscribe for More Information
15:43 EDTVRTXFDA panel votes 12 to 1 that data supports Orkambi approval
Subscribe for More Information
15:35 EDTVRTXFDA panel votes unanimously that data support Orkambi safety
Subscribe for More Information
15:35 EDTSBGISinclair Broadcast announces distribution deal with Chideo
Chideo announced a first-of-its-kind partnership with Sinclair Broadcast Group to expand Chideo's reach by 42 million households. Through this unique distribution deal, Sinclair will connect its broadcast and digital audience with Chideo's inspirational and entertaining content – all to benefit the world's leading charities. Sinclair's 161 local television stations will provide much-needed public awareness for these causes, as well as direct financial support from the sale of advertising and sponsorships around Chideo's rich collection of exclusive content from more than 100 celebrity ambassadors.
15:32 EDTVRTXFDA panel inconclusive on if Lumacaftor contributes to Orkambi effectiveness
Subscribe for More Information
12:37 EDTAPOLFor-profit education stocks slide after SEC charges ITT with fraud
Subscribe for More Information
10:23 EDTVRTXVertex shares halted while FDA panel meeting takes place
07:58 EDTVRTXFDA Pulmonary-Allergy Drugs Advisory Committee to hold a meeting
Subscribe for More Information
May 11, 2015
16:14 EDTOHRPOhr Pharmaceutical reports Q2 net loss ($3.4M) vs.($2M) in Q214
Subscribe for More Information
16:04 EDTUNXLUni-Pixel reports Q1 EPS (46c), consensus (44c)
Subscribe for More Information
10:09 EDTIRMHigh option volume stocks
Subscribe for More Information
07:40 EDTVRTXFocus on Vertex will shift to pricing after Orkambi FDA meeting, WSJ says
An FDA advisory committee that meets Tuesday to decide whether to recommend approval of Vertex’s Orkambi will be closely watched by health insurers and pharmacy-benefit managers concerned that the experimental cystic-fibrosis drug will be high-priced, said The Wall Street Journal. Vertex hasn’t announced a price, but analyst at JPMorgan predict the drug will have a wholesale price of about $287,000 annually per patient. Publicly traded PBM owners include Catamaran (CTRX), which is being acquired by UnitedHealth (UNH), CVS Health (CVS) and Express Scripts (ESRX). Reference Link
May 8, 2015
14:13 EDTVRTXOrkambi questions may make reimbursement talks harder, says Evercore ISI
Subscribe for More Information
10:10 EDTVRTXPiper confident in Vertex getting positive panel vote for Orkambi
Piper Jaffray said the briefing documents posted for next Tuesday's advisory committee meeting on Vertex's Orkambi combo drug did not raise any new or surprise safety concerns and that the efficacy concerns raised do not "hold much water" when compared to the unmet clinic benefit of the drug. The firm said it remains confident in a positive panel vote and approval of the drug by the May 5 PDUFA date and reiterate kits Overweight rating and $146 price target on Vertex shares.
09:28 EDTVRTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTVRTXFDA staff question if Vertex CF drug combo adds benefit over ivacaftor alone
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use